<DOC>
	<DOCNO>NCT01909479</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , parallel-group , multicenter study adult subject GHD ass safety efficacy long-acting , weekly injection modify hGH ( MOD-4023 ) .</brief_summary>
	<brief_title>A Phase 3 , Multicenter Study Designed To Evaluate The Efficacy And Safety Of A Long Acting Hgh Product ( Mod-4023 ) In Adult Subjects With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Men woman age 23 70 year old screening , inclusive GHD subject define Consensus guideline diagnosis treatment adult GH deficiency II ( 2007 ) . No rhGH replacement therapy use GH secretagogues least 9 month register investigational rhGH GH secretagogue product . The IGFI level screen â‰¤1 SDS age sex normal range accord central laboratory measurement Subjects stable diet exercise regime plan modify diet exercise least 12 month Subject DXA screening result interpretable accord study plan . Women pregnant breastfeeding ( least 6 month delay childbirth lactation ) Evidence growth benign intracranial tumor within last 12 month ( determine compare previous MRI new one obtain 6 month prior study entry clarify dynamic growth ) . History cancer . Exceptions exclusion criterion include resect situ carcinoma cervix squamous cell basal cell carcinoma skin complete local excision . Patients GHD attribute treatment intracranial malignant lesion childhood adulthood ( , tumor ) leukemia may also enrol study provide recurrencefree survival period least 5 year well document study record . Signs intracranial hypertension screen Heart insufficiency , NYHA class &gt; 2 ( Appendix B ) History overt diabetes mellitus ( include currently treat , wellcontrolled DM ) define accord American Diabetes Association ( ADA ) Criteriaa . A history gestational diabetes , resolve childbirth , exclusionary . History Acromegaly</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>